Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα AgonistMichael R. McKeown, Ravindra Majeti, Mei Wei Chen et al.|Cancer Discovery|2017Cited by 139
Abstract 1511: AML patient clustering by super-enhancers reveals an RARA associated transcription factor signaling partnerMichael R. McKeown, Christian Fritz, Ravindra Majeti et al.|Cancer Research|2017Cited by 0
Abstract PR05: SY-1425 (tamibarotene), a potent and selective RARα agonist, induces changes in the transcriptional regulatory circuit of AML cells leading to differentiationChristopher Fiore, Christian Fritz, Michael R. McKeown et al.|Clinical Cancer Research|2017Cited by 0